Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Firsov

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Antibiotiki|November 1, 1982
[Build up of a given concentration of tobramycin and sisomycin in the blood of young children by the intravenous infusion of the antibiotics according to a calculated regimen]A A Firsov, G F Pankova
Die Pharmazie|June 1, 1986
Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rateA A Firsov, V K Piotrovskii
Die Pharmazie|July 1, 1986
Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailabilityA A Firsov, V K Piotrovskii
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 2, 1999
In vitro dynamic model for determining the comparative pharmacology of fluoroquinolonesS H Zinner, A A Firsov
Antibiotiki I Meditsinskaia Biotekhnologiia = Antibiotics and Medical Biotechnology|July 1, 1985
[Kinetics of the antimicrobial effect in a dynamic system: the microcalorimetric recording method and choice of parameters for characterizing kinetic curves]V M Chernykh, A A Firsov
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|May 1, 1991
[Pharmacokinetics of protegentin, a combined preparation]E V Gagaeva, A A Firsov
Antibiotiki|May 1, 1980
[Pharmacokinetic interpretation of the myorelaxant effect of kanamycin]A A Firsov, V N Solov'ev
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Correlations between aminoglycoside pharmacokinetic parameters and patient's factors: from statement to implication for individual dosage designA A Firsov, V N Nasonov
Die Pharmazie|January 1, 1976
[Mathematical models of pharmacokinetics in chemotherapy]V Soloviev, V M Fishman, A A Firsov
Antibiotiki|April 1, 1977
[Optimal regime of intravenous administration of lincomycin in osteomyelitis]V G Koroleva, V M Fishman, A A Firsov
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Antibiotiki|November 1, 1982
[Build up of a given concentration of tobramycin and sisomycin in the blood of young children by the intravenous infusion of the antibiotics according to a calculated regimen]A A Firsov, G F Pankova
Die Pharmazie|June 1, 1986
Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rateA A Firsov, V K Piotrovskii
Die Pharmazie|July 1, 1986
Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailabilityA A Firsov, V K Piotrovskii
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 2, 1999
In vitro dynamic model for determining the comparative pharmacology of fluoroquinolonesS H Zinner, A A Firsov
Antibiotiki I Meditsinskaia Biotekhnologiia = Antibiotics and Medical Biotechnology|July 1, 1985
[Kinetics of the antimicrobial effect in a dynamic system: the microcalorimetric recording method and choice of parameters for characterizing kinetic curves]V M Chernykh, A A Firsov
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|May 1, 1991
[Pharmacokinetics of protegentin, a combined preparation]E V Gagaeva, A A Firsov
Antibiotiki|May 1, 1980
[Pharmacokinetic interpretation of the myorelaxant effect of kanamycin]A A Firsov, V N Solov'ev
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Correlations between aminoglycoside pharmacokinetic parameters and patient's factors: from statement to implication for individual dosage designA A Firsov, V N Nasonov
Die Pharmazie|January 1, 1976
[Mathematical models of pharmacokinetics in chemotherapy]V Soloviev, V M Fishman, A A Firsov
Antibiotiki|April 1, 1977
[Optimal regime of intravenous administration of lincomycin in osteomyelitis]V G Koroleva, V M Fishman, A A Firsov
Pageof 11